A phase 3 randomized, placebo‐controlled, double‐blind, clinical trial of the effect of modafinil on cancer‐related fatigue among 631 patients receiving chemotherapy
Pascal Jean‐Pierre(University of Miami), Judith O. Hopkins(Novant Health), Benjamin Esparaz(Heartland Cancer Research), Supriya G. Mohile(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Amy Hemstad(Metro-Minnesota Community Oncology Research Consortium), Joseph A. Roscoe(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Michelle C. Janelsins(University of Rochester), Luke J. Peppone(University of Rochester Medical Center)
Cited by 191
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Applied Discriminant Analysis
|Technometrics|1995|409